Maynard Um
-
-
-
-
-
-
-
NewAmsterdam Pharma Co NV (NAMS) PT Raised to $44 at RBC Capital
-
-
-
-
-
-
-
NewAmsterdam Pharma reports reduction in Alzheimer's biomarkers in trial
-
-
-
-
-
-
-
Cantor Fitzgerald Starts NewAmsterdam Pharma Co NV (NAMS) at Overweight
-
-
-
-
-
-
-
Piper Sandler Explores Direct and Indirect Catalysts for Selected Biotechnology Companies
-
-
-
-
-
-
-
Piper Sandler Reiterates Overweight Rating on NewAmsterdam Pharma Co NV (NAMS)
-
-
-
-
-
-
-
NewAmsterdam Pharma (NAMS) Announces Appointments of Mark C. McKenna and Wouter Joustra to its Board of Directors
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

